REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Beijing Konruns Pharmaceutical Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Beijing Konruns Pharmaceutical Co.,Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Beijing Konruns Pharmaceutical Co., Ltd. researches, develops, manufactures and sells pharmaceutical products for tumor and blood-related diseases. The company was founded in 2003 and is headquartered in Beijing, China.

Headquarters
11 Xingsheng S. R. Miyun Dist. Econ. Dev. Area Beijing
Beijing; Beijing; Postal Code: 101500

Contact Details: Purchase the Beijing Konruns Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.konruns.cn

Basic Information
Total Employees:
Purchase the Beijing Konruns Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Beijing Konruns Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Beijing Konruns Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Beijing Konruns Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
September 03, 2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
31.74%
Purchase this report to view the information.
10.15%
Purchase this report to view the information.
6%
Purchase this report to view the information.
2.44%
Purchase this report to view the information.
2.36%
Subsidiaries
Beijing Aixinwan Pharmaceutical Technology Co., Ltd.
100%
Hebei Kangchen Pharmaceutical Co., Ltd.
100%
Hunan Jingxiangyuan Snake Breeding Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Beijing Konruns Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
20.67%▲
Total operating revenue
19.6%▲
Operating profit (EBIT)
40.27%▲
EBITDA
35.02%▲
Net Profit (Loss) for the Period
56.86%▲
Total assets
8.15%▲
Total equity
4.58%▲
Operating Profit Margin (ROS)
3.53%▲
Net Profit Margin
5.42%▲
Return on Equity (ROE)
0.46%▲
Debt to Equity Ratio
2.44%▲
Quick Ratio
-3.9%▼
Cash Ratio
-0.87%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo